Tectonic Therapeutic (TECX) Other Operating Expenses (2017 - 2023)
Tectonic Therapeutic (TECX) posted quarterly Other Operating Expenses of $83.7 million for Q2 2023, up 490.06% quarter-over-quarter from $14.2 million in Q4 2017.
Tectonic Therapeutic (TECX) Other Operating Expenses (2017 - 2023) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Other Operating Expenses for 2 consecutive years, with $83.7 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Other Operating Expenses changed N/A year-over-year to $83.7 million; the TTM figure through Mar 2024 stood at $83.7 million (changed N/A YoY), while the FY2023 annual figure was $83.7 million, changed N/A from the prior year.
- Other Operating Expenses rose to $83.7 million in Q2 2023 per TECX's latest filing, from $14.2 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $83.7 million in Q2 2023 and bottomed at $83.7 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 83.74 Mn |
| Dec 31, 2017 | 14.19 Mn |